Tamara Dake

Tamara Dake has a strong background in biology and research, with experience in various roles and companies. Tamara is currently the Director of Biology at Odyssey Therapeutics since November 2021. Previously, they worked at Novartis Institutes for BioMedical Research (NIBR) as a Senior Principal Scientist from September 2017 to November 2021. Prior to that, they were a Research Team Lead at Merrimack Pharmaceuticals from September 2013 to September 2017. Tamara started their career as a Postdoctoral Research Fellow at Dana-Farber Cancer Institute, Harvard Medical School from April 2005 to August 2013, where they made significant contributions to the understanding of PI3k isoforms in breast development and cancer.

Tamara Dake holds a PhD in Neurobiology with summa cum laude from the University of Ulm, Germany.